171 related articles for article (PubMed ID: 33780491)
1. Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist.
Sheng G; Yuan H; Jin L; Ranjit S; Panov J; Lu X; Levi M; Glazer RI
PLoS One; 2021; 16(3):e0248996. PubMed ID: 33780491
[TBL] [Abstract][Full Text] [Related]
2. MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment.
Yuan H; Wang X; Lu J; Zhang Q; Brandina I; Alexandrov I; Glazer RI
Oncotarget; 2018 Jan; 9(8):8042-8053. PubMed ID: 29487713
[TBL] [Abstract][Full Text] [Related]
3. LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells.
Liang H; Shen X
Biochem Biophys Res Commun; 2020 Jul; 528(2):330-335. PubMed ID: 32448508
[TBL] [Abstract][Full Text] [Related]
4. Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes.
Vieira CP; Fortmann SD; Hossain M; Longhini AL; Hammer SS; Asare-Bediako B; Crossman DK; Sielski MS; Adu-Agyeiwaah Y; Dupont M; Floyd JL; Li Calzi S; Lydic T; Welner RS; Blanchard GJ; Busik JV; Grant MB
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641586
[TBL] [Abstract][Full Text] [Related]
5. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
6. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
Masuelli L; Focaccetti C; Cereda V; Lista F; Vitolo D; Trono P; Gallo P; Amici A; Monaci P; Mattei M; Modesti M; Forni G; Kraus MH; Muraro R; Modesti A; Bei R
Int J Oncol; 2007 Feb; 30(2):381-92. PubMed ID: 17203220
[TBL] [Abstract][Full Text] [Related]
7. Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint therapy is associated with macrophage infiltration and Wnt pathway expression.
Yuan H; Jin L; Xiang H; Bhattacharya A; Brandish PE; Baltus G; Tong A; Zhou C; Glazer RI
Oncotarget; 2022 Dec; 13():1350-1358. PubMed ID: 36537914
[TBL] [Abstract][Full Text] [Related]
8. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
Quinet EM; Savio DA; Halpern AR; Chen L; Miller CP; Nambi P
J Lipid Res; 2004 Oct; 45(10):1929-42. PubMed ID: 15292374
[TBL] [Abstract][Full Text] [Related]
9. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
[TBL] [Abstract][Full Text] [Related]
10. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
11. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB mice.
Abe F; Younos I; Westphal S; Samson H; Scholar E; Dafferner A; Hoke TA; Talmadge JE
Int Immunopharmacol; 2010 Jan; 10(1):140-5. PubMed ID: 19833232
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of rat-neu
Sow HS; Benonisson H; Brouwers C; Linssen MM; Camps M; Breukel C; Claassens J; van Hall T; Ossendorp F; Fransen MF; Verbeek JS
Sci Rep; 2020 Mar; 10(1):3933. PubMed ID: 32127568
[TBL] [Abstract][Full Text] [Related]
18. MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors.
Juric V; O'Sullivan C; Stefanutti E; Kovalenko M; Greenstein A; Barry-Hamilton V; Mikaelian I; Degenhardt J; Yue P; Smith V; Mikels-Vigdal A
PLoS One; 2018; 13(11):e0207255. PubMed ID: 30500835
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.
Croci S; Nanni P; Palladini A; Nicoletti G; Grosso V; Benegiamo G; Landuzzi L; Lamolinara A; Ianzano ML; Ranieri D; Dall'Ora M; Iezzi M; De Giovanni C; Lollini PL
Breast Cancer Res; 2015 May; 17(1):70. PubMed ID: 25997501
[TBL] [Abstract][Full Text] [Related]
20. Autophagy inhibition upregulates CD4
Zarogoulidis P; Petanidis S; Domvri K; Kioseoglou E; Anestakis D; Freitag L; Zarogoulidis K; Hohenforst-Schmidt W; Eberhardt W
Mol Oncol; 2016 Dec; 10(10):1516-1531. PubMed ID: 27692344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
